v3.26.1
SEGMENT INFORMATION - Narrative (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
segment
Dec. 31, 2025
USD ($)
Concentration Risk And Geographic Information [Line Items]    
Number of operating segments | segment 1  
Number of reportable segments | segment 1  
Accounts receivable, net | $ $ 903,914 $ 908,214 [1]
Sanofi    
Concentration Risk And Geographic Information [Line Items]    
Accounts receivable, net | $ $ 152,600 $ 148,000
Credit Concentration Risk | Accounts Receivable | Customer One    
Concentration Risk And Geographic Information [Line Items]    
Concentration risk, percentage 20.00% 20.00%
Credit Concentration Risk | Accounts Receivable | Customer Two    
Concentration Risk And Geographic Information [Line Items]    
Concentration risk, percentage   10.00%
[1]
(1)December 31, 2025 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026.